“Baltimore, Maryland–(Newsfile Corp. – June 7, 2021) – The Board and Management of Flavocure Biotech, Inc. (“Flavocure”) a drug discovery and development company, announced today the appointment of Dr Thomas F. Woolf, PhD, an expert in pharmaceutical sciences to the company’s Board of Advisors.”
“Flavocure is a clinical stage ready company, and its first drug candidate targets pancreatic adenocarcinoma which is currently uncurable.”
To read more:
https://finance.yahoo.com/news/flavocure-biotech-inc-announces-appointment-181600896.html